Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Recent Findings SGLT2-i consistently lower office SBP/DBP (2.54.0/1.52.0 mmHg) and 24-hour ambulatory BP (3.8/1.8 mmHg)
EMA statement on ongoing review of GLP-1 receptor agonists
40, FD&C Yellow No
Jana Richardson discuss the evolving and often overlooked pelvic floor and sexual health effects associated with GLP-1 medications
Why it matters: Patients whose prescription drug coverage is tied to a drugs list price could benefit from Novos cuts
One participant who suffered from borderline personality disorder (BPD) experienced a significant improvement in their mental health such that they were discharged from their psychiatry team
US$ 27.57
US$ 27.11
US$ 20.81
